Citations

Showing 10 of 108094 citations.

Ultrasonographic Detection and Surgical Retrieval of a Nonmetallic Twinkle Marker in Breast Cancer: Pilot Study
Jakub, James W. , Hesley, Gina K. , Larson, Nicholas B. , Yaszemski, Michael J. , Greenleaf, James F. , Urban, Matthew W. , Lee, Christine U. , Hesley, Gina , Urban, Matthew W , Lee, Christine , Jakub, James W , Larson, Nicholas B , Miller, Alan Lee

Mayo Clinic

Radiology: Imaging Cancer | November 11, 2022 | Volume: 4 | Issue: 6 | Pages: No page available

10.1148/rycan.220053 | PMID 36367449 Get It

Pancreatic tumor microenvironmental acidosis and hypoxia transform gold nanorods into cell-penetrant particles for potent radiosensitization
Rauta, Pradipta Ranjan , Mackeyev, Yuri , Sanders, Keith L. , Kim, Joseph Byung-Kyu, Gonzalez, Valeria , Zahra, Yasmin , Shohayeb, Muhammad A. , Abousaida, Belal , Vijay, Geraldine V. , Tezcan, Okan , Liopo, Anton V. , Carter, Rickey E. , Sanders, Keith , Gonzalez, Valeria V , Carter, Rickey E , Krishnan, Sunil , Mackeyev, Yuri , Derry, Paul J. , Zubarev, Eugene R. , Singh, Pankaj K.

Mayo Clinic

Science Advances | November 11, 2022 | Volume: 8 | Issue: 45 | Pages: No page available

10.1126/sciadv.abm9729 | PMID 36367938 Get It

Coating nanoparticles with stealth epilayers increases circulation time by evading opsonization, macrophage phagocytosis, and reticuloendothelial sequestration. However, this also reduces internalization by cancer cells upon reaching the tumor. We designed gold nanorods (GNRs) with an epilayer that retains stealth properties in circulation but transforms spontaneously in the acidotic tumor microenvironment to a cell-penetrating particle. We used a customized stoichiometric ratio of l -glutamic acid and l -lysine within an amphiphilic polymer of poly( l -glutamic acid-co- l -lysine), or P(Glu-co-Lys), to effect this transformation in acidotic environments. P(Glu-co-Lys)-GNRs were internalized by cancer cells to facilitate potent in vitro radiosensitization. When administered intravenously in mice, they accumulate in the periphery and core of tumors without any signs of serum biochemical or hematological alterations, normal organ histopathological abnormalities, or overt deterioration in animal health. Furthermore, P(Glu-co-Lys)-GNRs penetrated the tumor microenvironment to accumulate in the hypoxic cores of tumors to potently radiosensitize heterotopic and orthotopic pancreatic cancers in vivo.
Prognostic implications of atrial fibrillation in adults with Ebstein anomaly
Miguel, Irene Martín de , Madhavan, Malini , Miranda, William R. , Connolly, Heidi M. , Egbe, Alexander C. , Martín de Miguel, Irene

Mayo Clinic

Heart | November 11, 2022 | Volume: 109 | Issue: 6 | Pages: 442-448

10.1136/heartjnl-2022-321493 | PMID 36368881 Get It

Objective Supraventricular arrhythmias are common in adults with Ebstein anomaly (EA). However, there are limited data about prognostic implications of atrial fibrillation (AF) in this population. Accordingly, our aim was to assess the clinical profile and burden of AF in adults with EA, and the relationship between AF and outcomes. Methods and results Six hundred eighty-two consecutive adults with a median age of 36 (24–49) years from Mayo Clinic, Minnesota, USA, between 2003 and 2020 were included. Sustained episodes of AF, clinical, echocardiographic, rhythm and surgical data were collected. Prevalence of AF at baseline was 18% (126 patients); the first episode occurred at a mean age of 43±17 years. Patients with AF were older, were more likely men, and had hypertension, renal dysfunction, cardiac devices, and more advanced right-sided and left-sided remodelling. During a median follow-up of 156 (81–240) months, 62 patients (11%) developed incident AF. At the last encounter, prevalence of AF was 28% (188 patients); of those, 63 (34%) had recurrent AF. Hospitalisation for heart failure (HF) occurred in 51 patients (7%). AF (HR 2.32, 95% CI 1.18 to 4.47; p=0.01) was independently associated with hospitalisation for HF. All-cause death occurred in 53 patients (8%); it was more frequent in those with AF in the univariable analysis, although it did not remain significant in the multivariable analysis. Conclusions AF in EA develops at relatively young ages with one-third of the cohort exhibiting a recurrent pattern. Patients with AF had a higher prevalence of comorbidities and worse right-sided and left-sided cardiac remodelling. AF was independently associated with HF hospitalisation.
Pictorial Review of Common and Uncommon Pediatric Breast Lesions
Harper, Laura , Simmons, Curtis , Woodard, Genevieve A. , Solanki, Malvika , Bhatt, Asha A. , Harper, Laura K , Simmons, Curtis L , Solanki, Malvika H

Mayo Clinic

RadioGraphics | November 11, 2022 | Volume: 43 | Issue: 1 | Pages: No page available

10.1148/rg.220117 | PMID 36367821 Get It

The Rise of Medicare Advantage
Wang, Jennifer C. , Chen, Xiao T. , Callaghan, John J. , Berry, Daniel J. , Christ, Alexander B. , Heckmann, Nathanael D. , Chen, Xiao T , Bedard, Nicholas A. , Callaghan, John J , Berry, Daniel J , Christ, Alexander B , Heckmann, Nathanael , Piple, Amit S.

Mayo Clinic

Journal of Bone and Joint Surgery | November 11, 2022 | Volume: 104 | Issue: 24 | Pages: 2145-2152

10.2106/jbjs.22.00254 | PMID 36367757 Get It

Background: Medicare Advantage (MA) plans are popular among Medicare-eligible patients, but little is known about MA in lower-extremity total joint arthroplasty (TJA). The purpose of this study was to describe trends in MA utilization and analyze differences in patient characteristics and postoperative outcomes between patients undergoing primary TJA using traditional Medicare (TM) or MA plans. Methods: Patients ≥65 years of age who underwent primary total knee or total hip arthroplasty were identified using the Premier Healthcare Database. Patients were categorized into TM and MA cohorts. Data from 2004 to 2020 were used to describe trends in insurance coverage. Data from 2015 to 2020 were used to identify differences in patient characteristics and postoperative complications using ICD-10 codes. Multivariate analyses were performed using 2015 to 2020 data to account for potential confounders. Results: From 2004 to 2020, the proportion of patients with MA increased from 7.9% to 34.4%, while those with TM decreased from 83.7% to 54.0%. Of the 697,317 patients who underwent primary elective TJA from 2015 to 2020, 471,439 (67.6%) had TM coverage and 225,878 (32.4%) had MA coverage. The cohorts were similar in terms of age and sex. However, a higher proportion of Black patients (8.29% compared with 4.62%; p < 0.001) and a lower proportion of White patients (84.0% compared with 89.2%; p < 0.001) were enrolled in MA compared with TM. After controlling for confounders, patients with MA had higher odds of surgical site infection (adjusted odds ratio [aOR]: 1.15; 95% confidence interval [CI]: 1.04 to 1.47; p = 0.031), periprosthetic joint infection (aOR: 1.10; 95% CI: 1.03 to 1.18; p = 0.006), stroke (aOR: 1.15; 95% CI: 1.02 to 1.31; p = 0.026), and acute kidney injury (aOR: 1.08; 95% CI: 1.04 to 1.11; p < 0.001), but lower odds of urinary tract infection (aOR: 0.94; 95% CI: 0.90 to 0.98; p = 0.003). Conclusions: From 2004 to 2020, the number of patients utilizing MA increased markedly such that 1 in 3 were covered by MA in 2020. From 2015 to 2020, patients who were non-White were more likely to have MA than TM, and the MA group had a higher rate of several postoperative complications compared with the TM group. As TM claims data inform health-care policy and clinical decisions, this change portends future challenges, including limitations in arthroplasty registry research, an increase in the administrative burden of surgeons, and a potential worsening of social disparities in health care.
TSG-6 (Tumor Necrosis Factor-α-Stimulated Gene/Protein-6): An Emerging Remedy for Renal Inflammation
Jiang, Yamei , Glasstetter, Logan M., Lerman, Amir , Lerman, Lilach O. , Lerman, Amir

Mayo Clinic

Hypertension | November 11, 2022 | Volume: 80 | Issue: 1 | Pages: 35-42

10.1161/hypertensionaha.122.19431 | PMID 36367104 Get It

The inflammatory response is a major pathological feature in most kidney diseases and often evokes compensatory mechanisms. Recent evidence suggests that TSG-6 (tumor necrosis factor-α-stimulated gene/protein-6) plays a pivotal role in anti-inflammation in various renal diseases, including immune-mediated and nonimmune-mediated renal diseases. TSG-6 has a diverse repertoire of anti-inflammatory functions: it potentiates antiplasmin activity of IαI (inter-α-inhibitor) by binding to its light chain, crosslinks hyaluronan to promote its binding to cell surface receptor CD44, and thereby regulate the migration and adhesion of lymphocytes, inhibits chemokine-stimulated transendothelial migration of neutrophils by directly interacting with the glycosaminoglycan binding site of CXCL8 (CXC motif chemokine ligand-8), and upregulates COX-2 (cyclooxygenase-2) to produce anti-inflammatory metabolites. Hopefully, further developments can target this anti-inflammatory molecule to the kidney and harness its remedial properties. This review provides an overview of the emerging role of TSG-6 in blunting renal inflammation.
Magnetic resonance radiomic feature performance in pulmonary nodule classification and impact of segmentation variability on radiomics
Koo, Chi Wan , Kline, Timothy L. , Yoon, Joo Hee , Vercnocke, Andrew J. , Johnson, Mathew P, Suman, Garima , Lu, Aiming , Larson, Nicholas B. , Larson, Nicholas B

Mayo Clinic

The British Journal of Radiology | November 11, 2022 | Volume: 95 | Issue: 1140 | Pages: No page available

10.1259/bjr.20220230 | PMID 36367095 Get It

Objective: Investigate the performance of multiparametric MRI radiomic features, alone or combined with current standard-of-care methods, for pulmonary nodule classification. Assess the impact of segmentation variability on feature reproducibility and reliability. Methods: Radiomic features were extracted from 74 pulmonary nodules of 68 patients who underwent nodule resection or biopsy after MRI exam. The MRI features were compared with histopathology and conventional quantitative imaging values (maximum standardized uptake value [SUVmax] and mean Hounsfield unit [HU]) to determine whether MRI radiomic features can differentiate types of nodules and associate with SUVmax and HU using Wilcoxon rank sum test and linear regression. Diagnostic performance of features and four machine learning (ML) models were evaluated with area under the receiver operating characteristic curve (AUC) and 95% confidence intervals (CIs). Concordance correlation coefficient (CCC) assessed the segmentation variation impact on feature reproducibility and reliability. Results: Elevn diffusion-weighted features distinguished malignant from benign nodules (adjusted p < 0.05, AUC: 0.73–0.81). No features differentiated cancer types. Sixty-seven multiparametric features associated with mean CT HU and 14 correlated with SUVmax. All significant MRI features outperformed traditional imaging parameters (SUVmax, mean HU, apparent diffusion coefficient [ADC], T1, T2, dynamic contrast-enhanced imaging values) in distinguishing malignant from benign nodules with some achieving statistical significance (p < 0.05). Adding ADC and smoking history improved feature performance. Machine learning models demonstrated strong performance in nodule classification, with extreme gradient boosting (XGBoost) having the highest discrimination (AUC = 0.83, CI=[0.727, 0.932]). We found good to excellent inter- and intrareader feature reproducibility and reliability (CCC≥0.80). Conclusion: Eleven MRI radiomic features differentiated malignant from benign lung nodules, outperforming traditional quantitative methods. MRI radiomic ML models demonstrated good nodule classification performances with XGBoost superior to three others. There was good to excellent inter- and intrareader feature reproducibility and reliability. Advances in knowledge: Our study identified MRI radiomic features that successfully differentiated malignant from benign lung nodules and demonstrated high performance of our MR radiomic feature-based ML models for nodule classification. These new findings could help further establish thoracic MRI as a non-invasive and radiation-free alternative to standard practice for pulmonary nodule assessment.
Why has targeting EGFR aberrations in glioblastoma therapy had limited success?
Kizilbash, Sani H. , Kizilbash, Sani H

Mayo Clinic

Expert Review of Anticancer Therapy | November 11, 2022 | Volume: 22 | Issue: 12 | Pages: 1261-1263

10.1080/14737140.2022.2146581 | PMID 36367033 Get It

Rescue Endovascular Treatment of Patients With Emergent Large Vessel Occlusion Attributed to Intracranial Atherosclerosis: A Systematic Review and Meta‐Analysis
Chalhoub, Reda , Lena, Jonathan , Zaidat, Osama O. , Spiotta, Alejandro M , Kasab, Sami Al , Almallouhi, Eyad , Murad, Mohammad Hassan, Almallouhi, Eyad , Murad, M. Hassan , Kicielinski, Kimberly , Brennan, Emily , Havenon, Adam de

Mayo Clinic

Stroke: Vascular and Interventional Neurology | November 11, 2022 | Volume: 3 | Issue: 1 | Pages: No page available

10.1161/svin.122.000510 | PMID 41585755 Get It

Background Patients with acute stroke presenting with large vessel occlusion secondary to intracranial atherosclerosis (ICAS‐LVO) may require rescue therapy (RT) in addition to mechanical thrombectomy to achieve and maintain successful recanalization. We performed a systematic review and meta‐analysis of comparative studies that reported outcomes of RT in patients with ICAS‐LVO to evaluate its safety and efficacy. Methods Databases searched include PubMed, CINAHL Complete, and Scopus from database date of inception through August 17, 2021. We included comparative studies that reported the outcomes of ICAS‐LVO RT compared with outcomes of patients with ICAS‐LVO who did not undergo RT or to those patients presenting with embolic large vessel occlusion (non–ICAS‐LVO). Meta‐analysis using the random‐effects model was used to combine estimates reporting odds ratios (ORs) and 95% CIs. Results A total of 9 nonrandomized studies were included: 5 studies in ICAS‐LVO RT versus ICAS‐LVO non‐RT analysis and 5 in ICAS‐LVO RT versus non‐ICAS LVO analysis. Rescue treatments included intra‐arterial antiplatelets, angioplasty, stenting, or a combination of treatments. Compared with non‐RT ICAS‐LVO, RT was associated with an increased favorable 90‐day outcome (OR, 3.19 [95% CI, 1.91–5.32]; I 2 = 14%) and decreased 90‐day mortality (OR, 0.35 [95% CI, 0.16–0.76]; I 2 = 21%). In the analysis of ICAS‐LVO RT versus embolic LV, the incidence of favorable 90‐day outcome and 90‐day mortality did not differ between ICAS‐LVO RT and non–ICAS‐LVO (OR, 0.97 [95% CI, 0.58–1.64; I 2 = 50%]; and OR, 1.22 [95% CI, 0.90–1.66; I 2 = 0%], respectively). Conclusions Rescue treatment is likely associated with better outcomes in patients with ICAS‐LVO. The outcomes of patients with ICAS‐LVO who receive RT may be comparable with patients with embolic large vessel occlusion (non–ICAS‐LVO).
Current Evidence and Future Perspectives of the Best Supplements for Cardioprotection: Have We Reached the Final Chapter for Vitamins?
Yasmin, Farah , Ali, Syed Hasan , Naeem, Aisha , Savul, Subhan, Afridi, Muhammad Sohaib Iqbal, Kamran, Neha, Fazal, Fawwad, Khawer, Shehryar, Savul, Ilma Saleh , Najeeb, Hala , Asim, Hamdoon Suharwardy, Nausherwan, Marium, Asghar, Muhammad Sohaib , Naeem, Aisha, Kamran, Neha

Mayo Clinic

Reviews in Cardiovascular Medicine | November 11, 2022 | Volume: 23 | Issue: 11 | Pages: No page available

10.31083/j.rcm2311381 | PMID 39076184 Get It

Cardiovascular disease (CVD), a broad-spectrum term comprising coronary artery disease, stroke, hypertension, and heart failure, presents as one of the most significant strains on global healthcare systems. Coronary artery disease, caused by atherosclerosis, has various modifiable risk factors such as dietary changes and exercise. Since these risk factors are found to be linked to oxidative stress and inflammations, the dietary supplementation with vitamins’ role in treating and preventing the diseases has been of much debate. With various vitamins having anti-inflammatory and antioxidative properties, studies have explored their correlation with cardiovascular health. Therefore, this narrative review explores and evaluates the benefits and risks of all vitamin supplementations in patients with CVD and provides future recommendations.